Login / Signup

Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease.

Matthew P WallenA HallK A DiasJ S RamosS E KeatingA J WoodwardTina L SkinnerG A MacdonaldR ArenaJ S Coombes
Published in: Alimentary pharmacology & therapeutics (2017)
Ventilatory threshold is reduced in patients with advanced liver disease taking beta-blockers compared to those not taking the medication. This may incorrectly risk stratify patients on beta-blockers and has implications for patient management before and after liver transplantation. The oxygen uptake efficiency slope was not influenced by beta-blockers and may therefore be a better measure of cardiopulmonary performance in this patient population.
Keyphrases